Citation Tools

Download PDFPDF

Original research
Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study

Download to a citation manager

Cite this article as:
van der Heijde D, Gensler LS, Maksymowych WP, et al
Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study